InsiderTrades

Form 4 for BCYC BICYCLE THERAPEUTICS PLC

Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001415889-25-000926 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-06 2025-01-02 BCYC Arroyo Santiago Chief DEVELOPMENT Off A - Grant $0.00 +35.0K 74.0K +90% $0
D 2025-01-06 2025-01-02 BCYC Arroyo Santiago Chief DEVELOPMENT Off S - Sale $14.09 -4,943 69.1K -7% -$69.6K
D 2025-01-06 2025-01-02 BCYC Arroyo Santiago Chief DEVELOPMENT Off A - Grant $0.00 +87.0K 87.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-01-02 A A 35,000 $0.00 74,000 D — — (F1) Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2026 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. (F2) Each RSU represents a contingent right to receive one ordinary share.
2 Common Ordinary Shares 2025-01-02 S D 4,943 $14.09 69,057 D — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Employee Stock Option (right to buy) 2025-01-02 A A 87,000 $0.00 87,000 D $14.00 · — to 2035-01-02 87,000 Ordinary Shares (F5) This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares in 36 equal monthly installments thereafter.